Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
The Journal of Arthroplasty|January 15, 2022
Indication for Proximal Femoral Replacement Is Associated With Risk of FailureAthan G Zavras, Michael P Fice, Navya Dandu, et al.Journal of Orthopaedics|August 8, 2024
Outcomes of distal femoral replacement versus internal fixation for metastatic bone diseases of the distal femurAustin Yu, Thomas McCormack, Dylan Vance, et al.Journal of Surgical Oncology|January 30, 2024
Internal hemipelvectomy: A single institution's learning curve and longitudinal experienceRajko S Vucicevic, Athan G Zavras, Michael P Fice, et al.Surgical Oncology|August 11, 2024
Does adding sacroiliac (type IV) resection to periacetabular (type II) resection increase complications or provide worse clinical outcomes? An institutional experience and systematic reviewRajko S Vucicevic, Athan G Zavras, Michael P Fice, et al.Surgical Oncology|September 23, 2022
Neoadjuvant radiation influences the pseudocapsule in soft tissue sarcoma: A histopathologic and radiographic evaluationNicholas J Waldvogel, Sarah C Tepper, Linus Lee, et al.Surgical Oncology|August 9, 2024
Radiotherapy leads to improved overall survival in patients undergoing resection for Undifferentiated pleomorphic sarcomaSarah C Tepper, Linus Lee, Michael P Fice, et al.Surgical Oncology|June 1, 2023
Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and survival in undifferentiated pleomorphic sarcoma (NLR, PLR, and overall survival in UPS)Sarah C Tepper, Linus Lee, Michael P Fice, et al.Journal of Orthopaedics|October 1, 2024
A comparison of dislocation risk between dual mobility and traditional constructs used in proximal femoral replacementAthan G Zavras, Rajko S Vucicevic, Michael P Fice, et al.Biochemical and Biophysical Research Communications|January 8, 2013
Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapyYimin Ma, Yongxin Ren, Ethan Q Han, et al.Gene|November 12, 2002
The human homolog of yeast SEP1 is a novel candidate tumor suppressor gene in osteogenic sarcomaKunbo Zhang, Norbert Dion, Bruno Fuchs, et al.Pageof 9